RECORD // Company

Picard Medical, Inc.

Built 2026-11-22T01:07:27Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001437749-26-037258

ItemValuePeriodFormFiledAccessionReport
Revenue$217,0003 months ended 2026-09-3010-Q2026-11-160001437749-26-0372582026-11-22 01:07 UTCReport an error
Net income (loss)$-2,219,0003 months ended 2026-09-3010-Q2026-11-160001437749-26-0372582026-11-22 01:07 UTCReport an error
Cash and cash equivalents$67,000at 2026-09-3010-Q2026-11-160001437749-26-0372582026-11-22 01:07 UTCReport an error
Contract liabilities (total)$0at 2026-09-3010-Q2026-11-160001437749-26-0372582026-11-22 01:07 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0002030617
Ticker
PMI
CUSIP
71953R108
Record ID
sx:sec:0002030617

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

29 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 01:07 UTCReport an error
SIC industry3841 Surgical & Medical Instruments & Apparatus2026-11-16SEC EDGAR company profile2026-11-22 01:07 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-22 01:07 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 01:07 UTCReport an error
Business address1992 E. SILVERLAKE RD., TUCSON, AZ, 857132026-11-16SEC EDGAR company profile2026-11-22 01:07 UTCReport an error
ExchangesNYSE2026-11-16SEC EDGAR company profile2026-11-22 01:07 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$4,940,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 01:07 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-27,002,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 01:07 UTCReport an error
Total assets (at 2025-12-31)$22,548,0002025-12-3110-K, XBRL Assets2026-11-22 01:07 UTCReport an error
Stockholders' equity (at 2025-12-31)$3,789,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 01:07 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$7,451,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 01:07 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-15,673,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 01:07 UTCReport an error
Remaining performance obligation (at 2025-12-31)$02025-12-3110-K, XBRL RevenueRemainingPerformanceObligation2026-11-22 01:07 UTCReport an error
Operating lease liabilities (at 2025-12-31)$420,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 01:07 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-10-23)On October 20, 2026, Picard Medical, Inc. (the “Company”) entered into a Warrant Amendment and Exchange Agreement (the “Exchange Agreement”) with the placement agent (the “Warrant Holder”) of its private placement closed on December 26, 2025 (the “December 2025 Private Placement”), and such Warrant Holder’s employee designee (“Designee”, together with the Warrant Holder, “Warrant Holders”) as a party by joinder who is bound by the surrender, release and other provisions of the Exchange Agreement applicable to him. Pursuant to the Exchange Agreement the Warrant Holders agreed to surrender the Warrants described below in exchange for 200,000 shares of the Company’s common stock. The Exchange…2026-10-23SEC EDGAR 8-K 0001437749-26-033423 (text as filed, excerpt)2026-11-22 01:07 UTCReport an error
8-K Item 3.02, Unregistered Sales of Equity Securities (filed 2026-10-23)The information in Item 1.01 is incorporated herein by reference. On October 22, 2026, after satisfaction of the applicable conditions, the Company issued 200,000 Exchange Shares to the Warrant Holders solely in exchange for the Warrants, without cash or other consideration to the Company. The Company relied on the exemption from registration under Section 3(a)(9) of the Securities Act. No broker, dealer or other person solicited the exchange for a commission or other remuneration.2026-10-23SEC EDGAR 8-K 0001437749-26-033423 (text as filed, excerpt)2026-11-22 01:07 UTCReport an error
8-K Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (filed 2026-10-13)On October 7, 2026, the Board of Directors (the “Board”) of Picard Medical Inc. (the “Company”) approved an amendment (the “Amendment”) to the Company’s Amended and Restated Bylaws (as amended from time to time, the “Amended and Restated Bylaws”), effective immediately. The Amendment amends Section 9 of the Amended and Restated Bylaws to decrease the quorum required for a meeting of the Company's stockholders. Specifically, the quorum requirement was reduced from a majority of the voting power of the shares of the Company’s capital stock issued and outstanding and entitled to vote, to thirty-three and one-third percent (33 1/3%) of the voting power of such shares. This Amendment complies…2026-10-13SEC EDGAR 8-K 0001437749-26-032542 (text as filed, excerpt)2026-11-22 01:07 UTCReport an error
8-K Item 2.03, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (filed 2026-10-06)On September 30, 2026 (the “Issuance Date”), Picard Medical, Inc. (the “Company”) issued three separate unsecured convertible notes (collectively, the “Notes”) to three accredited investors (each, a “Holder” and collectively, the “Holders”) in the aggregate principal amount of $1.0 million. Each Note bears interest at a rate of 3.0% per annum, calculated on the basis of a 360-day year, from the Issuance Date until paid or converted in accordance with its terms. The Notes mature on September 30, 2027 (the “Maturity Date”). The outstanding balance under each Note consists of its unpaid principal and accrued and unpaid interest (the “Outstanding Balance”). Upon the occurrence and during the…2026-10-06SEC EDGAR 8-K 0001437749-26-032125 (text as filed, excerpt)2026-11-22 01:07 UTCReport an error
8-K Item 3.02, Unregistered Sales of Equity Securities (filed 2026-10-06)The information set forth in Item 2.03 of this Current Report on Form 8-K is incorporated into this Item 3.02 by reference. Any issuance of shares of Common Stock upon conversion of the Notes, and any issuance of the pre-funded warrants and the shares of Common Stock upon exercise thereof, will be made pursuant to an available exemption from registration under the Securities Act. The Company expects to rely on Section 4(a)(2) of the Securities Act for the issuance of the pre-funded warrants and, to the extent applicable, Section 3(a)(9) of the Securities Act for securities issued upon conversion or exercise, provided that the conditions of the applicable exemption are satisfied at the time…2026-10-06SEC EDGAR 8-K 0001437749-26-032125 (text as filed, excerpt)2026-11-22 01:07 UTCReport an error
Largest institutional holder #1 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$413,0182026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error
Largest institutional holder #2 (13F as filed): AQR CAPITAL MANAGEMENT LLC$350,7062026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error
Largest institutional holder #3 (13F as filed): JANE STREET GROUP, LLC$225,1752026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error
Largest institutional holder #4 (13F as filed): IEQ CAPITAL, LLC$47,5102026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error
Largest institutional holder #5 (13F as filed): RENAISSANCE TECHNOLOGIES LLC$28,1842026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error
Largest institutional holder #6 (13F as filed): FMR LLC$24,6902026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error
Largest institutional holder #7 (13F as filed): UBS Group AG$20,5332026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error
Largest institutional holder #8 (13F as filed): Cerity Partners LLC$18,8912026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error
Largest institutional holder #9 (13F as filed): Mariner, LLC$12,4262026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error
Largest institutional holder #10 (13F as filed): WEALTH ENHANCEMENT ADVISORY SERVICES, LLC$11,6782026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 01:07 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.